Molecular evidence for the involvement of NR2B subunit containing N-methyl-D-aspartate receptors in the development of morphine-induced place preference

Neuroscience

Volumn 101, Issue 3, 2000, Pages 601-606

  Narita, M ^a   Aoki, T ^a   Suzuki, T ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

opioid receptor; Conditioned place preference; Glutamate; Morphine; Seizure; Western blotting

Indexed keywords

ANTIBODY; MORPHINE; MU OPIATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONDITIONING; CONTROLLED STUDY; FOREBRAIN; HIPPOCAMPUS; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PRIORITY JOURNAL; SEIZURE; SEIZURE THRESHOLD; VENTRAL TEGMENTUM;

ANIMALS; ANTIBODIES; BEHAVIOR, ANIMAL; GLUTAMIC ACID; MALE; MICE; MICE, INBRED STRAINS; MORPHINE; MORPHINE DEPENDENCE; N-METHYLASPARTATE; NEURONS; PROSENCEPHALON; RECEPTORS, N-METHYL-D-ASPARTATE; REWARD; SEIZURES;

EID: 0034669073     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(00)00405-X     Document Type: Article

References (43)

1. A synaptic model of memory: long-term potentiation in the hippocampus
2. Molecular dissection of native mammalian forebrain NMDA receptors containing the NR1 C2 exon: direct demonstration of NMDA receptors comprising NR1, NR2A, and NR2B subunits within the same complex
3. Excitatory amino acid receptors and synaptic plasticity
4. The NMDA receptor antagonist dizocilpine (MK-801) stereoselectively inhibits morphine-induced place preference conditioning in mice
5. Neurobiology of opiate abuse
6. Role of mesolimbic dopamine system in morphine dependence
7. Interactions between ifenprodil and the NR2B subunit of the N-methyl-D-aspartate receptor
8. NMDA receptor subunit gene expression in the rat brain: a quantitative analysis of endogenous mRNA levels of NR1Com, NR2A, NR2B, NR2C, NR2D and NR3A
9. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse
10. Anticonvulsant properties of phencyclidine-like drugs in mice
11. Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits
12. MK801 prevents the developmennt of behavioral sensitization during repeated morphine administration
13. Neurotransmitter regulation of dopamine neurons in the ventral tegmental area
14. Drugs of abuse: anatomy, pharmacology and function of reward pathways
15. Glutamatergic control of dopamine release in the rats striatum: evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals
16. Molecular diversity of the NMDA receptor channel
17. Differential tyrosine phosphorylation of N-methyl-D-aspartate receptor subunits
18. Excitatory amino acids as a final common pathway for neurologic disorders
19. Protein measurement with the Folin phenol reagent
20. Mechanisms underlying long-term potentiation of synaptic transmission
21. N-methyl-D-aspartate receptor structure and function
22. Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNA
23. Excitatory amino acid neurotoxicity and neurogenerative disease
24. Heteromeric NMDA receptors: Molecular and functional distinction of subtypes
25. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors
26. Involvement of the carboxyl-terminal region in modulation by TPA of the NMDA receptor channel
27. Classification of compounds for prevention of NMDA-induced seizures/mortality, or maximal electroshock and pentylenetetrazole seizures in mice and antagonism of MK801 binding in vitro
28. Enhanced tyrosine phosphorylation of the 2B subunit of the N-methyl-D-aspartate receptor in long-term potentiation
29. Changing subunit composition of heteromeric NMDA receptors during development of rat cortex
30. Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat
31. Drug interactions in the reinforcing effects of over-the-counter cough syrups
32. Effects of the non-competitive NMDA receptor antagonist ifenprodil on the morphine-induced place preference in mice
33. Effects of the non-competitive NMDA receptor antagonist ketamine on the morphine-induced place preference in mice
34. Regulation of NMDA receptor phosphorylation by alternative splicing of the C-terminal domain
35. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK801
36. Role of the NMDA receptor complex in the DMCM-induced seizure in mice
37. N-Methyl-D-aspartic acid-receptor antagonists block morphine-induced conditioned place preference in rats
38. Stable expression and characterization of recombinant human heteromeric N-methyl-D-aspartate receptor subtypes NMDAR1A/2A and NMDAR1A/2B in mammalian cells
39. 2+-sensitivity of cloned NMDA receptor
40. Developmental changes in distribution of NMDA receptor channel subunit mRNAs
41. Distinct distributions of five N-methyl-D-aspartate receptor channel subunit mRNAs in the forebrain
42. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors
43. Cloning, expression and modulation of a mouse NMDA receptor subunit